scispace - formally typeset
S

Sophie M. Morgani

Researcher at Memorial Sloan Kettering Cancer Center

Publications -  24
Citations -  1050

Sophie M. Morgani is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Embryonic stem cell & Epiblast. The author has an hindex of 11, co-authored 20 publications receiving 720 citations. Previous affiliations of Sophie M. Morgani include University of Edinburgh & University of Copenhagen.

Papers
More filters
Journal ArticleDOI

Totipotent Embryonic Stem Cells Arise in Ground-State Culture Conditions

TL;DR: 2i and LIF support a totipotent state comparable to early embryonic cells that coexpress embryonic and extraembryonic determinants, as well as Nanog-positive epiblast-like ESCs.
Journal ArticleDOI

TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1.

TL;DR: RREB1 provides a molecular link between RAS and TGF-β pathways for coordinated induction of developmental and fibrogenic EMTs, and increases the understanding of the regulation of epithelial plasticity and its pathophysiological consequences in development, fibrosis and cancer.
Journal ArticleDOI

Micropattern differentiation of mouse pluripotent stem cells recapitulates embryo regionalized cell fate patterning

TL;DR: The mouse micropattern system offers a robust scalable method to generate regionalized cell types present in vivo, resolve how signals promote distinct identities and generate patterns, and compare mechanisms operating in vivo and in vitro and across species.
Journal ArticleDOI

The many faces of Pluripotency: in vitro adaptations of a continuum of in vivo states

TL;DR: The continuum of pluripotency existing within the mammalian embryo is discussed, using the mouse as a model, and the cognate stem cell types that can be derived and propagated in vitro are discussed.
Journal ArticleDOI

LIF supports primitive endoderm expansion during pre-implantation development.

TL;DR: It is found that activation of JAK/STAT signalling downstream of LIF occurs initially throughout the pre-implantation embryo, but later marks the PrE, suggesting a mechanism by which the embryo adjusts the relative ratio of the primary lineages in response to experimental manipulation.